Therapies
Explore our current therapies in development
V-Shield
V-Shield utilizes a proprietary combination of small molecules to inhibit the binding of the SARS-CoV-2 virus to the ACE2 antigen. V-Shield constituents also disrupt the coronavirus viral membrane while leaving the host membrane unharmed. the novel coronavirus intelligently shuts down ACE2 expression while stimulating the overexpression of cytokines that lead to pneumonia. Our therapeutic blend also reverses this action by restoring the expression of ACE2 and downregulating excessive cytokine production. This results in dramatically reduced probability of infection, and reduced severity of symptoms if infected. It's like wearing a shield without having to!
Betagen
Type-1 diabetics have lost their insulin producing beta cells due to an autoimmune reaction. By combining our proprietary agents in an injectable collagen matrix, clusters of beta cells are shown to regrow in current animal models. Combined with anti-rejection drugs, many of the deleterious effects of Type-1 diabetes can be mitigated.
Resgel
Our Resgel cancer therapy reduces tumor size by injecting a proprietary gel loaded with our specialized small molecule blend that targets cancer cells but is harmless to normal cells. This results in far fewer side effects (no nausea or hair loss), while dramatically reducing tumor size before removal.